Corrigendum to "Menetrier's disease coexisting with ulcerative colitis and sclerosing cholangitis" [Dig. Liver Dis. 40 (2008) 78-80] (DOI:10.1016/j.dld.2007.10.001);Menetrier's disease coexisting with ulcerative colitis and sclerosing cholangitis

Digestive and Liver Disease

Volumn 40, Issue 1, 2008, Pages 78-79

  Hatemi, I ^a   Caglar, E ^a   Aksoy, D ^a   Goksel, S ^a   Dobrucali, A ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; MESALAZINE; METHYLPREDNISOLONE; URSODEOXYCHOLIC ACID;

ADULT; BACTERIUM CULTURE; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ENDOSCOPIC BIOPSY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FECES CULTURE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; HYPOALBUMINEMIA; LETTER; LIVER BIOPSY; MALE; MENETRIER DISEASE; PHYSICAL EXAMINATION; REMISSION; SCLEROSING CHOLANGITIS; SEROLOGY; ULCERATIVE COLITIS; UPPER GASTROINTESTINAL TRACT;

EID: 37149031030     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.09.010     Document Type: Erratum

References (11)

1. Xiao S.Y., and Hart J. Marked gastric foveolar hyperplasia associated with active cytomegalovirus infection. Am J Gastroenterol 96 (2001) 223-226
2. Kawasaki M., Hizawa K., Aoyagi K., Nakamura S., and Fujishima M. Menetrier's disease associated with Helicobacter pylori infection: resolution of enlarged gastric folds and hypoproteinemia after antibacterial treatment. Am J Gastroenterol 92 (1997) 1909-1912
3. Burdick J.S., Chung E., Tanner G., Sun M., Paciga J.E., Cheng J.Q., et al. Treatment of Menetrier's disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med 7 343 (2000) 1697-1701
4. Settle S.H., Washington K., Lind C., Itzkowitz S., Fiske W.H., Burdick J.S., et al. Chronic treatment of Menetrier's disease with Erbitux: clinical efficacy and insight into pathophysiology. Clin Gastroenterol Hepatol 3 (2005) 654
5. Green B.T., and Branch M.S. Menetrier's disease treated with octreotide long-acting release. Gastrointest Endosc 60 (2004) 1028-1029
6. Ladas S.D., Tassios P.S., Malamou H.C., Protopapa D.P., and Raptis S.A. Omeprazole induces a long-term clinical remission of protein-losing gastropathy of Menetrier's disease. Eur J Gastroenterol Hepatol 9 (1997) 811-813
7. Sasaki E., Toyonaga A., Murayama S., Kuboyama S., Sasaki S., Inuzuka S., et al. A case report of Menetrier's disease developed in a patient with ulcerative colitis. Nippon Shokakibyo Gakkai Zasshi 88 (1991) 96-99
8. Ojeda E., Ruiz J., Cosme A., and Lobo C. Menetrier disease associated with ulcerative colitis. Response to the treatment with octreotide. Review of the diagnostic criteria and etiopathogenesis. Gastroenterol Hepatol 20 (1997) 175-179
9. Mirkovic D., Doder R., Ilic S., Mitrovic M., and Ignjatovic M. Menetrier's disease associated with ulcerative colitis. Vojnosanit Pregl 60 (2003) 747-751
10. Belhocine K., and Chaoui F. Menetrier disease and ulcerative colitis an unusual association. Gastroenterol Clin Biol 30 (2006) 1105-1107
11. Hemmings C.T. Menetrier's disease in a patient with ulcerative colitis: a case report and review of the literature. Pathology 39 (2007) 282-283